Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesDiseases and Disorders of the Ear, Nose, Mouth and ThroatDRG 152-otitis-media-and-uri-with-mcc
    Ask Trek AI about this page

    Otitis Media and URI with MCC: Inpatient Reimbursement Overview

    DRG 152 encompasses inpatient stays for otitis media and upper respiratory infection when a Major Complication or Comorbidity is present, increasing clinical complexity. Understanding this Diagnosis-Related Group matters for inpatient reimbursement because the Major Complication or Comorbidity designation raises resource intensity and influences Medicare payment under the inpatient prospective payment system.

    Customize your policy alerts

    Sign up for drg 152 policy alerts

    Get alerted when payer policies referencing 152 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 152 Overview

    DRG 152 covers inpatient admissions for otitis media and upper respiratory infections with at least one Major Complication or Comorbidity present. This Diagnosis-Related Group groups patients whose clinical complexity increases resource use and payment relative to cases without major complications. It is important for Medicare payment because the presence of a Major Complication or Comorbidity elevates the relative weight and influences hospital reimbursement under Medicare Severity Diagnosis-Related Group methodology. Accurate clinical documentation and coding determine assignment to this DRG and thus affect payment.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Acute inpatient antimicrobial strategy trials: studies comparing different empirical antibiotic regimens, dosing strategies, or routes (intravenous versus early switch to oral) for hospitalized children and adults admitted with severe otitis media or upper respiratory infection complications with major complications or comorbidities (the MCC population). These trials focus on time to clinical improvement, resolution of complication (eg, mastoiditis, meningitis, severe pneumonia), length of stay, and adverse events in medically complex patients. Results inform providers about safe, effective inpatient treatment algorithms and help payers evaluate cost-effective antibiotic stewardship and stewardship-driven length-of-stay reductions.
    • Comparative effectiveness and surgical timing studies: pragmatic trials or cohort studies assessing outcomes of medical management versus surgical interventions (for example tympanostomy tube placement or drainage procedures) and optimal timing of such procedures in patients with otitis media complicated by major comorbidities or refractory upper respiratory infection sequelae. These investigations enroll hospitalized patients who have failed initial medical therapy or who have anatomical or systemic risk factors and compare rates of complication resolution, readmission, and functional outcomes. Evidence guides clinicians on indications and timing for procedures in higher-risk inpatients and helps payers understand downstream utilization and potential cost offsets from timely intervention.
    • Post-discharge outcomes and readmission prevention studies: prospective observational studies and quality-improvement trials that follow discharged patients with prior hospitalization for complicated otitis media or severe URI to assess readmission drivers, outpatient recurrence, functional recovery, antibiotic-related adverse events, and adherence to follow-up care. These studies often target high-risk subgroups (young children, elderly, immunocompromised, or those with multiple chronic conditions) to evaluate transitional care interventions such as early outpatient follow-up, telehealth monitoring, or home nursing support. Findings are relevant to providers for optimizing discharge planning and to payers for designing bundled-payment or care-management programs that reduce preventable readmissions and total episode costs.

    Related Codes

    135-SINUS-AND-MASTOID-PROCEDURES-WITH-CC-MCC

    Sinus and Mastoid Procedures with CC/MCC: Inpatient Reimbursement Overview

    136-SINUS-AND-MASTOID-PROCEDURES-WITHOUT-CC-MCC

    Sinus and Mastoid Procedures without CC/MCC: Inpatient Reimbursement Overview

    137-MOUTH-PROCEDURES-WITH-CC-MCC

    Mouth Procedures with CC/MCC: Inpatient Reimbursement Overview

    138-MOUTH-PROCEDURES-WITHOUT-CC-MCC

    Mouth Procedures without CC/MCC: Inpatient Reimbursement Overview

    139-SALIVARY-GLAND-PROCEDURES

    Salivary Gland Procedures: Inpatient Reimbursement Overview

    140-MAJOR-HEAD-AND-NECK-PROCEDURES-WITH-MCC

    Major Head and Neck Procedures with MCC: Inpatient Reimbursement Overview

    141-MAJOR-HEAD-AND-NECK-PROCEDURES-WITH-CC

    Major Head and Neck Procedures with CC: Inpatient Reimbursement Overview

    142-MAJOR-HEAD-AND-NECK-PROCEDURES-WITHOUT-CC-MCC

    Major Head and Neck Procedures without CC/MCC: Inpatient Reimbursement Overview

    143-OTHER-EAR-NOSE-MOUTH-AND-THROAT-O-R-PROCEDURES-WITH-MCC

    Other Ear, Nose, Mouth and Throat O.R. Procedures with MCC: Inpatient Reimbursement Overview

    144-OTHER-EAR-NOSE-MOUTH-AND-THROAT-O-R-PROCEDURES-WITH-CC

    Other Ear, Nose, Mouth and Throat O.R. Procedures with CC: Inpatient Reimbursement Overview

    Showing 1–10 of 24

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.